BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:REQUEST X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:W. Europe Standard Time BEGIN:STANDARD DTSTART:16011028T030000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10 TZOFFSETFROM:+0200 TZOFFSETTO:+0100 END:STANDARD BEGIN:DAYLIGHT DTSTART:16010325T020000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3 TZOFFSETFROM:+0100 TZOFFSETTO:+0200 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT ATTENDEE;CN="Møterom E-helse 4316 Cisco - 15 pl";CUTYPE=RESOURCE;ROLE=NON- PARTICIPANT;RSVP=TRUE:mailto:Moterom.e-helse.4316.-.10pl@ehelse.no ATTENDEE;CN="Espen Stranger Seland - Helsedirektoratet (espen.stranger.sela nd@ehelse.no)";RSVP=TRUE:mailto:espen.stranger.seland@ehelse.no ATTENDEE;CN="Øyvind Aassve";RSVP=TRUE:mailto:oeyaas@sykehuspartner.no ATTENDEE;CN=MICHAL.CERMAK@NHN.NO;RSVP=TRUE:mailto:MICHAL.CERMAK@NHN.NO ATTENDEE;CN=info@hl7.no;ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:info@hl7.no ATTENDEE;CN="Ciprian-Virgil Gerstenberger";ROLE=OPT-PARTICIPANT;RSVP=TRUE:m ailto:Ciprian.Gerstenberger@ehealthresearch.no ATTENDEE;CN="Jorn Agnar Solheim";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:jorn agnar.solheim@tietoevry.com ATTENDEE;CN="Anita Lorck";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:Anita.Lorck @ehelse.no ATTENDEE;CN="Svensøy, Jarle";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:jarle.s vensoy@capgemini.com ATTENDEE;CN="Christoffer Berglund";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:ch ristoffer.berglund@bliksund.com ATTENDEE;CN="Neuman, Torgny Erik Fredrik";ROLE=OPT-PARTICIPANT;RSVP=TRUE:ma ilto:torgny.erik.fredrik.neuman@helse-vest-ikt.no ATTENDEE;CN="Sassan Sokhan-Sanj";ROLE=OPT-PARTICIPANT;RSVP=TRUE:invalid:nom ail ATTENDEE;CN="Liv Oftedal Rossow";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:liv. rossow@origo.oslo.kommune.no ATTENDEE;CN="Adam Kover";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:adam.kover@f elleskatalogen.no ATTENDEE;CN="Sæle, Line Andreassen";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto: LineAndreassen.Saele@fhi.no ATTENDEE;CN="Jon Aarbakke";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:ja@promis. no ATTENDEE;CN="Andreas Atteraas Grønbekk";ROLE=OPT-PARTICIPANT;RSVP=TRUE:inv alid:nomail ATTENDEE;CN="Frank Robert Samdahl";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:Fr ank.Robert.Samdahl@ehelse.no ATTENDEE;CN="Linn Brandt";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:Linn.Brandt @ehelse.no ATTENDEE;CN="Magnus Alsaker";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:maal@dip s.no ATTENDEE;CN="Bjørnsen-Hagen, Eilev";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto: Eilev.Hagen@hemit.no ATTENDEE;CN="Holm, Roar Jæger";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:roar. jeger.holm@helse-vest-ikt.no ATTENDEE;CN="Tore Hugo Bjerke";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:tohbje @sykehuspartner.no ATTENDEE;CN="Henrik Næss";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:Henrik.Nae ss@ehelse.no ATTENDEE;CN="Nordeide, Anders Tangedal";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mail to:anders.tangedal.nordeide@helse-vest-ikt.no ATTENDEE;CN="Armann Helgason";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:Armann. Helgason@nhn.no ATTENDEE;CN="Eirik Myklebost";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:eirikm@ aboveit.no ATTENDEE;CN="Mario G. Hyland (AEGIS.net)";ROLE=OPT-PARTICIPANT;RSVP=TRUE:ma ilto:mario.hyland@aegis.net ATTENDEE;CN="Frank Bråthen";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:Frank.Br athen@nhn.no ATTENDEE;CN="Soerlien, Ingvar";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:ingvar .soerlien@siemens-healthineers.com ATTENDEE;CN="Bente Cecilie By Jansen";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto :bente.jansen@felleskatalogen.no ATTENDEE;CN="Frank Alexander Berger";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto: uxbfra@sykehuspartner.no ATTENDEE;CN="Ronny Bergeton Hansen";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:R onny.b.Hansen@tietoevry.com ATTENDEE;CN="Richard Hagen";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:richard.h agen@skilnet.no ATTENDEE;CN="Andy Harrison";ROLE=OPT-PARTICIPANT;RSVP=TRUE:invalid:nomail ATTENDEE;CN="Andersen, Ronny Heitmann";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailt o:ronny.heitmann.andersen@helse-vest-ikt.no ATTENDEE;CN="Anders Stormo";ROLE=OPT-PARTICIPANT;RSVP=TRUE:invalid:nomail ATTENDEE;CN="Tore Dundas";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:tdu@dips.no ATTENDEE;CN="Ravik, Anders";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:anders.ra vik@capgemini.com ATTENDEE;CN="Øystein Nytrø";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:nytroe@ ntnu.no ATTENDEE;CN="Trond André Aag";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:tpette rs@sykehuspartner.no ATTENDEE;CN="Einar Johan Amlie";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:Einar JohanBraem.Amlie@lds.no ATTENDEE;CN="Øivind Riis";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:Oivind.Rii s@so-hf.no ATTENDEE;CN="Helge Skjønberg";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:Helge. Skjonberg@sykehuspartner.no ATTENDEE;CN="Jostein Ven";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto:Jostein.Ven @ehelse.no ATTENDEE;CN="Jørn Andre Jørgensen";ROLE=OPT-PARTICIPANT;RSVP=TRUE:mailto: Jorn.Andre.Jorgensen@ehelse.no CLASS:PUBLIC CREATED:20220502T082112Z DESCRIPTION:Velkommen til møte #12 i FHIR fagforum\n\nFHIR fagforum (FFF) er et åpent forum om bruk og implementering av HL7 FHIR i Norge. FFF er åpent for alle.\n\nAgenda og annen informasjon legges ut på: https://hl7 norway.github.io/best-practice/docs/FHIR-faglig-forum/\n\n \n\n___________ _____________________________________________________________________ \n\n Microsoft Teams-møte \n\nBli med fra datamaskin eller mobilapp \n\nKlikk her for å delta i møtet \n\nFinn ut mer | Møtealternativer \n\n______________________________________________________________________ __________ \n\n \n\n DTEND;TZID="W. Europe Standard Time":20220511T150000 DTSTAMP:20220322T105144Z DTSTART;TZID="W. Europe Standard Time":20220511T130000 LAST-MODIFIED:20220502T082112Z LOCATION:Microsoft Teams-møte\; Møterom E-helse 4316 Cisco - 15 pl ORGANIZER;CN="Thomas Tveit Rosenlund":mailto:Thomas.Tveit.Rosenlund@ehelse. no PRIORITY:5 SEQUENCE:1 SUMMARY;LANGUAGE=no:FHIR fagforum #12 TRANSP:OPAQUE UID:040000008200E00074C5B7101A82E0080000000010BBFD6F84E6D701000000000000000 01000000091FC02D9E36A0648A10BA31CA5A825D1 X-ALT-DESC;FMTTYPE=text/html:

Velkommen til \;møte #12 i FHIR fagforum

< span style='color:black'>FHIR fagforum (FFF) er et åpent forum om bruk og implementering av HL7 FHIR i Norge. FFF er åpent for alle.

Agenda og annen informasjon legges ut på: \;https://h l7norway.github.io/best-practice/docs/FHIR-faglig-forum/

 \;

______________________________________________________________________ __________

Microsoft Teams-møte

Bli med fra datamaskin eller mobilapp

Klikk her for å delta i møtet

________ ________________________________________________________________________

 \;

X-MICROSOFT-CDO-BUSYSTATUS:BUSY X-MICROSOFT-CDO-IMPORTANCE:1 X-MICROSOFT-DISALLOW-COUNTER:FALSE X-MS-OLK-APPTLASTSEQUENCE:2 X-MS-OLK-APPTSEQTIME:20220131T142643Z X-MS-OLK-AUTOFILLLOCATION:FALSE X-MS-OLK-CONFTYPE:0 BEGIN:VALARM TRIGGER:-PT15M ACTION:DISPLAY DESCRIPTION:Reminder END:VALARM END:VEVENT END:VCALENDAR